Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Xenetic Biosciences (XBIO) Other Operating Expenses (2025)

Xenetic Biosciences (XBIO) has disclosed Other Operating Expenses for 4 consecutive years, with $304724.0 as the latest value for Q2 2023.

  • For the quarter ending Q2 2023, Other Operating Expenses changed N/A year-over-year to $304724.0, compared with a TTM value of $304724.0 through Mar 2024, up 561.64%, and an annual FY2013 reading of $10668.0, down 94.48% over the prior year.
  • Other Operating Expenses was $304724.0 for Q2 2023 at Xenetic Biosciences, up from $78936.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $304724.0 in Q2 2023 and bottomed at $304724.0 in Q2 2023.